#biotech

🏢Release 📈 Stocks

Innovent Biologics Phase 3 Trial Hits Primary Endpoints for Gastric Cancer

October 23, 2026 (18 days ago)

Innovent Biologics' G-HOPE-001 trial confirms clinical efficacy for its ADC candidate, marking a major milestone for the company's oncology pipeline and potential…

01801.HK

🌍 ASIA Read More →

🏢Release 📈 Stocks

Qlife Secures ISO 13485 Certification for At-Home PHE Diagnostic Testing

October 23, 2026 (18 days ago)

Qlife Holding AB reaches a key regulatory milestone with ISO 13485 certification for its at-home PHE diagnostic solution, strengthening the Egoo platform's…

QLIFE

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Warhound Launches $200 Million Venture for Genetically Enhanced K9 Units

October 23, 2026 (18 days ago)

Warhound enters the defense tech sector with a $200 million investment in cybernetically enhanced K9 units designed to bolster U.S. military capabilities…

Warhound

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Bristol-Myers Squibb Combination Therapy Cuts Disease Progression Risk by 27%

October 23, 2026 (18 days ago)

Bristol-Myers Squibb reports positive clinical trial results as a combination therapy featuring nivolumab reduces disease progression risk by 27% with a median…

BMY

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

Insilica Integrates 60 ProtoPRED Models to Boost ToxIndex Capabilities

October 22, 2026 (18 days ago)

Insilica expands its ToxIndex platform through a partnership with ProtoQSAR, adding 60 ProtoPRED models to enhance the speed and transparency of in-silico…

INSILICA PROTOQSAR

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

Photocure Appoints Dennis Camporeale as CFO to Lead Financial Operations

October 22, 2026 (19 days ago)

Photocure ASA appoints industry veteran Dennis Camporeale as CFO, effective October 26, 2026, bringing 25 years of senior financial expertise to the…

PHO

🌍 EUROPE Read More →

🏢Release 📈 Stocks

PleoPharma Reports New Survey Data on Cannabis Withdrawal Symptoms in Women

October 22, 2026 (19 days ago)

Clinical-stage developer PleoPharma publishes new survey data characterizing cannabis withdrawal symptoms and cessation patterns among women.

PLEOPHARMA

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

CSL Names Deborah Waterhouse as CEO Effective February 1, 2027

October 22, 2026 (19 days ago)

CSL Limited appoints Deborah Waterhouse as CEO, effective February 1, 2027, signaling a long-term leadership transition for the global biotech firm.

CSL

🌍 OCEANIA Read More →

⚡Ad-hoc 📈 Stocks

Klaria Pharma Extends Rights Issue Period to November 6 Following Demand

October 22, 2026 (19 days ago)

Klaria Pharma extends its 147.6 million SEK rights issue subscription period to November 6, 2026, after securing 2.2 million SEK in additional…

KLAR

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Alethios Launches No-Code Research Suite to Reduce Clinical Study Costs

October 22, 2026 (19 days ago)

Alethios introduces a no-code research suite that integrates wearables, AI biomarkers, and lab tests to reduce the financial burden of traditional clinical…

Alethios

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Danaher's Genedata Integrates NVIDIA BioNeMo to Accelerate Drug Discovery

October 22, 2026 (19 days ago)

Danaher-owned Genedata is deploying NVIDIA's BioNeMo AI models to enhance biopharma R&D, signaling a strategic push to integrate advanced generative AI into…

NVDA DHR

🌍 EUROPE Read More →

🏢Release 📈 Stocks

OPKO Health Sells BioReference Assets to Labcorp for $722 Million

October 21, 2026 (19 days ago)

OPKO Health shares gain momentum as the company offloads BioReference Health assets to Labcorp in a $722 million deal aimed at bolstering…

OPK LH

🌍 AMERICAS Read More →